Banque Pictet & Cie SA Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Banque Pictet & Cie SA decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 325,054 shares of the healthcare conglomerate's stock after selling 1,988 shares during the quarter. UnitedHealth Group comprises approximately 1.4% of Banque Pictet & Cie SA's investment portfolio, making the stock its 14th biggest position. Banque Pictet & Cie SA's holdings in UnitedHealth Group were worth $170,247,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in UNH. Citizens National Bank Trust Department raised its stake in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after buying an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group during the 4th quarter worth $515,000. Full Sail Capital LLC grew its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Up 1.4%

UNH traded up $4.30 during trading on Friday, reaching $303.81. The stock had a trading volume of 9,789,082 shares, compared to its average volume of 7,670,765. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's 50 day moving average is $316.42 and its two-hundred day moving average is $442.28. The company has a market capitalization of $275.60 billion, a price-to-earnings ratio of 12.72, a P/E/G ratio of 1.45 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the company earned $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Analysts Set New Price Targets

UNH has been the topic of several recent analyst reports. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a report on Friday, June 20th. Piper Sandler reduced their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a research note on Wednesday, June 11th. Finally, Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, June 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $415.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.